MedPath

Brief Negotiated Interview (BNI) for dropouts from Opioid Agonist Treatment: An open-label, randomized controlled trial

Not Applicable
Conditions
Health Condition 1: F112- Opioid dependence
Registration Number
CTRI/2024/01/061387
Lead Sponsor
DR ROSHAN BHAD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Registered in the clinic in the two-year period before the selection month, Having a working mobile phone number, Diagnosed as suffering from opioid dependence syndrome as per ICD 10, Initiated on OAT at least one month before the assessment date, Unilaterally discontinued medicine by not receiving even a single dose of OAT medicine in the 30-days period before the intervention period, Use of illicit opioids at least once in last 30 days

Exclusion Criteria

Drop out due to migration, incarceration, under treatment for SUD/Medical illnesses or death, Presence of psychiatric/physical morbidity affecting telephonic interview, Not willing to take part in the interview

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the proportion of drop-out participants re-entering treatment after receiving telephonic brief negotiated interview with the proportion of drop-out participants re-entering treatment who received simple adviceTimepoint: 1 month and 3 months post intervention
Secondary Outcome Measures
NameTimeMethod
To assess the number of days patient remains in treatment after re-entryTimepoint: within 3 months of re-entry
© Copyright 2025. All Rights Reserved by MedPath